Clinical Trial Update: A Clinical Trial of the Vessel Sealing System (LigaSure) in Azygoportal Disconnection and Splenectomy in Patients With Portal Hypertension [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the LigaSure Vessel Sealing System in azygoportal disconnection and splenectomy for portal hypertension due to liver cirrhosis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis
• Portal Hypertension

Drugs mentioned

• LIGASURE Vessel Sealing System

Snippet

Sponsor: Shanghai Changzheng Hospital | Conditions: Liver Cirrhosis | Phase 4 | Status: COMPLETED